INMT and early-onset autosomal dominant Alzheimer disease: In contrast, conditions such as Alzheimer’s disease and ALS involve INMT’s interaction with sigma-1 receptors and neuroprotective signaling, highlighting its relevance beyond neurotransmitter methylation [78].